Angelica acutiloba Kitagawa Extract Attenuates DSS-Induced Murine Colitis

被引:24
作者
Jang, Jong-Chan [1 ]
Lee, Kang Min [2 ]
Ko, Seong-Gyu [2 ]
机构
[1] Kyung Hee Univ, Coll Korean Med, Dept Korean Med, 26 Kyungheedae Ro, Seoul 130701, South Korea
[2] Kyung Hee Univ, Coll Korean Med, Lab Clin Biol & Pharmacogen, 26 Kyungheedae Ro, Seoul 130701, South Korea
关键词
INFLAMMATORY-BOWEL-DISEASE; DEXTRAN SULFATE SODIUM; EPITHELIAL BARRIER FUNCTION; ULCERATIVE-COLITIS; INTESTINAL INFLAMMATION; ALTERNATIVE MEDICINE; INTERFERON-GAMMA; CROHNS-DISEASE; INTERLEUKIN-12; POLYSACCHARIDES;
D O I
10.1155/2016/9275083
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
We examined the protective effects of Angelica acutiloba Kitagawa (AAK) extract on a murine model of acute experimental colitis. Colitis was induced by 4% dextran sulfate sodium (DSS) in the drinking water of male C57BL/6 mice, for 7 consecutive days. Oral administration of AAK extract (500 mg/kg/day) significantly alleviated DSS-induced symptoms such as anorexia, weight loss, events of diarrhea or bloody stools, and colon shortening. Histological damage was also ameliorated, as evidenced by the architectural preservation and suppression of inflammatory cell infiltration in colonic samples. Treatment improved the colonic mRNA expression of different inflammatory markers: cytokines, inducible enzymes, matrix metalloproteinases, and tight junction-related proteins. In the isolated serum, IgE levels were downregulated. Collectively, these findings indicate the therapeutic potentials of AAK as an effective complementary or alternative modality for the treatment of ulcerative colitis.
引用
收藏
页数:13
相关论文
共 80 条
[21]   Quantitative Analysis of Marker Compounds in Angelica gigas, Angelica sinensis, and Angelica acutiloba by HPLC/DAD [J].
Jeong, Su Yang ;
Kim, Hye Mi ;
Lee, Kyu Ha ;
Kim, Kyu Yeob ;
Huang, Dae Sun ;
Kim, Jong Hwan ;
Seong, Rack Seon .
CHEMICAL & PHARMACEUTICAL BULLETIN, 2015, 63 (07) :504-511
[22]   Anti-allergic effects and mechanisms of action of the ethanolic extract of Angelica gigas in dinitrofluorobenzene-induced inflammation models [J].
Joo, Seong Soo ;
Park, Dongsun ;
Shin, Sunhee ;
Jeon, Jeong Hee ;
Kim, Tae Kyun ;
Choi, Young Jin ;
Lee, Sun Hee ;
Kim, Jeong Seon ;
Park, Sung Kyeong ;
Hwang, Bang Yeon ;
Lee, Do Ik ;
Kim, Yun-Bae .
ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY, 2010, 30 (02) :127-133
[23]   Colitis in mice lacking the common cytokine receptor γ chain is mediated by IL-6-producing CD4+ T cells [J].
Kai, Y ;
Takahashi, I ;
Ishikawa, H ;
Hiroi, T ;
Mizushima, T ;
Matsuda, C ;
Kishi, D ;
Hamada, H ;
Tamagawa, H ;
Ito, T ;
Yoshizaki, K ;
Kishimoto, T ;
Matsuda, H ;
Kiyono, H .
GASTROENTEROLOGY, 2005, 128 (04) :922-934
[24]   Systematic review: adherence issues in the treatment of ulcerative colitis [J].
Kane, SV .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 23 (05) :577-585
[25]   Herbal Medicine in the Treatment of Ulcerative Colitis [J].
Ke, Fei ;
Yadav, Praveen Kumar ;
Ju, Liu Zhan .
SAUDI JOURNAL OF GASTROENTEROLOGY, 2012, 18 (01) :3-10
[26]   L-cysteine supplementation attenuates local inflammation and restores gut homeostasis in a porcine model of colitis [J].
Kim, C. J. ;
Kovacs-Nolan, J. ;
Yang, C. ;
Archbold, T. ;
Fan, M. Z. ;
Mine, Y. .
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2009, 1790 (10) :1161-1169
[27]   STUDIES ON POLYSACCHARIDES FROM ANGELICA-ACUTILOBA .5. MOLECULAR AGGREGATION AND ATNICOMPLEMENTARY ACTIVITY OF ARABINOGALACTAN FROM ANGELICA-ACUTILOBA [J].
KIYOHARA, H ;
YAMADA, H ;
CYONG, JC ;
OTSUKA, Y .
JOURNAL OF PHARMACOBIO-DYNAMICS, 1986, 9 (04) :339-346
[28]   The PepT1-transportable soy tripeptide VPY reduces intestinal inflammation [J].
Kovacs-Nolan, Jennifer ;
Zhang, Hua ;
Ibuki, Masahisa ;
Nakamori, Toshihiro ;
Yoshiura, Keiko ;
Turner, Patricia V. ;
Matsui, Toshiro ;
Mine, Yoshinori .
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2012, 1820 (11) :1753-1763
[29]  
KUMAZAWA Y, 1982, IMMUNOLOGY, V47, P75
[30]   Review article: complementary and alternative therapies for inflammatory bowel disease [J].
Langmead, L ;
Rampton, DS .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 23 (03) :341-349